Thus, future studies should focus on the role of DEL-1 in atherosclerosis and aortic aneurysm, as a modulator of the immune response with antiinflammatory properties is likely to have a therapeutic potential in these pathologies. This evidence concerns the gene EDIL3 and aortic aneurysm.